Healthpluser

Spread the love

<figure class="img_container" style="float:left;margin-right:10px;width:350px;;margin-bottom:5px;max-width:100%;"><img width="590" height="442" class="unveil" loading="eager" style="width:100%;max-height:100%" src="https://img.etb2bimg.com/files/cp/upload-1716881542-ethealthworld.webp" data-src="https://etimg.etb2bimg.com/photo/117979185.cms" captionrendered="1" alt=""><figcaption class="caption"></figcaption></figure>Bengaluru: <a id="21921600" type="General" weightage="100" keywordseo="Becton-Dickinson" source="keywords" meta.keywordsubtype="org" meta.entityname="Becton Dickinson" meta.hostid="266" meta.entityid="Becton Dickinson" class="news-keywords" href="/tag/becton+dickinson">Becton Dickinson</a> beat expectations for first-quarter results and said its board has authorized a plan to separate its <a id="25340974" type="General" weightage="20" keywordseo="life-sciences-unit" source="keywords" class="news-keywords" href="/tag/life+sciences+unit">life sciences unit</a> on Wednesday, as the <a id="21357603" type="General" weightage="20" keywordseo="medical-device-maker" source="keywords" class="news-keywords" href="/tag/medical+device+maker">medical device maker</a> aims to focus on its core business. "We believe the separation will position New BD as a differentiated MedTech leader and enable optimized investment," said CEO <a id="25340973" type="General" weightage="20" keywordseo="Tom-Polen" source="keywords" class="news-keywords" href="/tag/tom+polen">Tom Polen</a>. <!– PROMOSLOT_M –> The company expects to announce more details on the separation plans by the end of fiscal 2025. Becton’s life sciences division makes diagnostic products such as those used to detect infectious diseases and cancers. Earlier this week, the Financial Times reported activist investor Starboard Value had taken a stake in Becton and was pushing the company to sell its life sciences unit. <!– PROMOSLOT_M –><!– PROMOSLOT –> The company also raised the lower end of its <a id="25249838" type="General" weightage="20" keywordseo="fiscal-2025-profit-forecast" source="keywords" class="news-keywords" href="/tag/fiscal+2025+profit+forecast">fiscal 2025 profit forecast</a> to a range of $14.30 to $14.60 per share, compared to the previous range of $14.25 to $14.60 each. Becton’s <a id="20025825" type="General" weightage="20" keywordseo="total-sales" source="keywords" class="news-keywords" href="/tag/total+sales">total sales</a> for the reported quarter came in at $5.17 billion, above analysts’ estimates of $5.1 billion, according to data compiled by LSEG. On an adjusted basis, the company reported a per-share profit of $3.43, beating analysts’ average expectation of $2.98. (Reporting by Kamal Choudhury, Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Alan Barona) </body>","next_sibling":[{"msid":117918195,"title":"Becton Dickinson looks to divest life sciences unit at $30 billion valuation, source says","entity_type":"ARTICLE","link":"/news/medical-devices/becton-dickinson-looks-to-divest-life-sciences-unit-at-30-billion-valuation-source-says/117918195","link_next_mobile":"/news/medical-devices/becton-dickinson-looks-to-divest-life-sciences-unit-at-30-billion-valuation-source-says/117918195?next=1","category_name":null,"category_name_seo":"medical-devices"}],"related_content":[],"seoschemas":false,"social_share":{"fb":"/information/medical-devices/becton-looks-to-separate-life-sciences-unit-after-upbeat-quarterly-results/117979004?utm_source=fb&utm_medium={{DEVICE_TYPE}}","x":"/information/medical-devices/becton-looks-to-separate-life-sciences-unit-after-upbeat-quarterly-results/117979004?utm_source=twitter&utm_medium={{DEVICE_TYPE}}","whatsapp":"/information/medical-devices/becton-looks-to-separate-life-sciences-unit-after-upbeat-quarterly-results/117979004?utm_source=wapp&utm_medium={{DEVICE_TYPE}}","linkdin":"/information/medical-devices/becton-looks-to-separate-life-sciences-unit-after-upbeat-quarterly-results/117979004?utm_source=linkedin&utm_medium={{DEVICE_TYPE}}","telegram":"/information/medical-devices/becton-looks-to-separate-life-sciences-unit-after-upbeat-quarterly-results/117979004?utm_source=telegram&utm_medium={{DEVICE_TYPE}}","copy":"/information/medical-devices/becton-looks-to-separate-life-sciences-unit-after-upbeat-quarterly-results/117979004?utm_source=copy&utm_medium={{DEVICE_TYPE}}"},"cat_msid":44909127,"cat_sub_msid":false,"msid":117979004,"entity_type":"ARTICLE","title":"Becton appears to separate life sciences unit after upbeat quarterly outcomes","synopsis":"Earlier this week, the Monetary Occasions reported activist investor Starboard Worth had taken a stake in Becton and was pushing the corporate to promote its life sciences unit.","titleseo":"medical-devices/becton-looks-to-separate-life-sciences-unit-after-upbeat-quarterly-results","standing":"ACTIVE","authors":[],"analytics":{"feedback":0,"views":178,"shares":0,"engagementtimems":694000},"Alttitle":{"minfo":""},"next_promo_stories":[{"id":"117674599","type":"next_article"}],"artag":"Reuters","artdate":"2025-02-06 15:12:40","lastupd":"2025-02-06 15:17:56","breadcrumbTags":["Becton Dickinson","fiscal 2025 profit forecast","Tom Polen","medical device maker","quarterly results","total sales","life sciences unit"],"secinfo":{"seolocation":"medical-devices/becton-looks-to-separate-life-sciences-unit-after-upbeat-quarterly-results"}}” data-type=”information” id=”news_dtl_117979004″ page-title=”Becton appears to separate life sciences unit after upbeat quarterly outcomes”>

Earlier this week, the Monetary Occasions reported activist investor Starboard Worth had taken a stake in Becton and was pushing the corporate to promote its life sciences unit.

Reuters

Up to date On Feb 6, 2025 at 03:17 PM IST

Learn by:

100 Business Professionals

Learn by
100 Business Professionals

Bengaluru: <a id=” captionrendered=”1″ data-src=”https://etimg.etb2bimg.com/picture/117979185.cms” top=”442″ href=”/tag/becton+dickinson” keywordseo=”Becton-Dickinson” loading=”keen” meta.entityid=”Becton Dickinson” meta.entityname=”Becton Dickinson” meta.hostid=”266″ meta.keywordsubtype=”org” supply=”key phrases” src=”https://img.etb2bimg.com/information/cp/upload-1716881542-ethealthworld.webp” sort=”Normal” weightage=”100″ width=”590″>Becton Dickinson beat expectations for first-quarter outcomes and mentioned its board has licensed a plan to separate its life sciences unit on Wednesday, because the medical device maker goals to concentrate on its core enterprise.

“We imagine the separation will place New BD as a differentiated MedTech chief and allow optimized funding,” mentioned CEO Tom Polen.

The corporate expects to announce extra particulars on the separation plans by the tip of fiscal 2025.

Becton’s life sciences division makes diagnostic merchandise comparable to these used to detect infectious ailments and cancers.

Earlier this week, the Monetary Occasions reported activist investor Starboard Worth had taken a stake in Becton and was pushing the corporate to promote its life sciences unit.

The corporate additionally raised the decrease finish of its fiscal 2025 profit forecast to a variety of $14.30 to $14.60 per share, in comparison with the earlier vary of $14.25 to $14.60 every.

Becton’s total sales for the reported quarter got here in at $5.17 billion, above analysts’ estimates of $5.1 billion, in accordance with information compiled by LSEG.

On an adjusted foundation, the corporate reported a per-share revenue of $3.43, beating analysts’ common expectation of $2.98. (Reporting by Kamal Choudhury, Christy Santhosh and Sriparna Roy in Bengaluru; Modifying by Alan Barona)